The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders—and reduce the tragic outcomes they cause, a large new study ...

(The Conversation) – A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He ...

Painkillers are at the center of our nation’s opioid crisis. So much so that Florida received a $3 billion settlement a few ...

The government has launched £20m worth of grants for technology to help fight drug and alcohol addiction in the UK. The funding, which will be delivered through Innovate UK, aims to support the ...

Douglas County commissioners will consider how to allocate opioid-settlement and special alcohol tax funding on Wednesday – and whether to change the way those requests are handled in the future. The ...

Is it just me, or have you noticed the disproportionate number of students who have addictions today? I hear Generation Z students freely acknowledge addictions to pot, vaping, sex, alcohol, and even ...

As someone with more than 20 years of recovery, I’ve seen what does and does not work when it comes to helping people take back their lives from substance use and move forward. People need safe ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION) A patient of mine, ...

Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...